Debarati Mazumder
About Debarati Mazumder
Debarati Mazumder is the Scientific Associate Director at Bristol Myers Squibb in Bengaluru, Karnataka, India, with extensive experience in drug discovery and translational research.
Title
Debarati Mazumder is the Scientific Associate Director at Bristol Myers Squibb in Bengaluru, Karnataka, India. Her responsibilities in this role involve leading scientific research and projects to drive the company's objectives in the pharmaceutical and biotechnology sectors.
Company
Debarati Mazumder currently works at Bristol Myers Squibb as the Scientific Associate Director, where she leverages her extensive experience in translational sciences and drug discovery. Bristol Myers Squibb is known for its focus on innovation and research, making Mazumder's role pivotal in advancing healthcare solutions.
Work Experience at Biocon BMS R and D Center
Before her current role, Debarati Mazumder held multiple positions at Biocon BMS R and D Center, Syngene Intl. Ltd. Her roles included Associate Research Director from 2020 to 2021, Senior Lead Investigator in Discovery Biology and Translational Sciences from 2018 to 2020, Lead Investigator in In vitro Pharmacology from 2016 to 2018, and Senior Principal Investigator from 2014 to 2016. She started as a Principal Investigator I from 2012 to 2014 and was Associate Scientific Manager from 2009 to 2012. During this time, she significantly contributed to drug discovery and target validation.
Education and Expertise
Debarati Mazumder received her PhD in Bioorganic Chemistry from Yale University, after a year enrolled for PhD in Chemistry and Chemical Biology at Cornell University. She obtained her Master of Science in Chemistry from the Indian Institute of Technology, Bombay, and her Bachelor of Science in Chemistry from Presidency University. Her academic background forms a solid foundation for her research expertise in areas like label-free proteomics, induced pluripotent stem cells, and translational research.
Background
Debarati Mazumder's career began with a postdoctoral fellowship at Harvard University from 2007 to 2009. Her career trajectory includes significant work in early target validation, fibrosis research, and drug discovery. She led the development of automation and miniaturization capabilities at BBRC, enhancing their drug discovery program throughput. Her comprehensive experience in assay development, screening, and mechanistic studies spans multiple therapeutic areas, reinforcing her status as a leader in her field.